A detailed history of Fairman Group, LLC transactions in Accolade, Inc. stock. As of the latest transaction made, Fairman Group, LLC holds 1,137,287 shares of ACCD stock, worth $3.58 Million. This represents 3.95% of its overall portfolio holdings.

Number of Shares
1,137,287
Previous 1,137,287 -0.0%
Holding current value
$3.58 Million
Previous $4.07 Billion 7.54%
% of portfolio
3.95%
Previous 4.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$9.22 - $15.02 $368,800 - $600,800
-40,000 Reduced 3.4%
1,137,287 $11.9 Billion
Q4 2023

Mar 26, 2024

BUY
$6.5 - $12.85 $7.65 Million - $15.1 Million
1,177,287 New
1,177,287 $14.1 Billion

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $227M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Fairman Group, LLC Portfolio

Follow Fairman Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairman Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairman Group, LLC with notifications on news.